Company Filing History:
Years Active: 2005-2008
Title: Cornelia Liepke: Innovator in Antimicrobial and Bifidogenic Peptides
Introduction
Cornelia Liepke is a prominent inventor based in Hannover, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antimicrobial and bifidogenic peptides. With a total of 2 patents, her work has implications for both medical and commercial applications.
Latest Patents
Liepke's latest patents include innovative inventions such as antimicrobial bolisin peptides. This invention relates to antibiotically effective peptides that are prepared for medical and commercial use through biotechnological methods and chemical synthesis. These peptides can be utilized in suitable galenic formulations as medicaments, animal medicaments, food additives, or preservatives to prevent microbial contamination in cosmetics and medical products. Another notable patent is for bifidogenic peptides, which are obtained by adding proteases to cow's milk or human milk, followed by a series of processes including incubation, centrifugation, and purification. The isolated peptides can be modified while maintaining their bifidogenic properties, offering potential health benefits.
Career Highlights
Throughout her career, Cornelia Liepke has worked with notable companies such as Pharis Biotec GmbH and Ipf Pharmaceuticals GmbH. Her expertise in peptide technology has positioned her as a key player in the biotechnology sector.
Collaborations
Liepke has collaborated with esteemed colleagues, including Wolf-Georg Forssmann and Hans-Dieter Zucht. These partnerships have further enhanced her research and development efforts in the field of peptides.
Conclusion
Cornelia Liepke's innovative work in antimicrobial and bifidogenic peptides showcases her significant contributions to biotechnology. Her patents reflect a commitment to advancing medical and commercial applications that can benefit society.